Evolution of Diabetes Technology

Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive autom...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinology and metabolism clinics of North America Vol. 49; no. 1; p. 1
Main Authors: Dovc, Klemen, Battelino, Tadej
Format: Journal Article
Language:English
Published: United States 01.03.2020
Subjects:
Artificial pancreas
Continuous glucose monitoring
Closed loop
Insulin pump
Technology
Type 1 diabetes
Self-monitoring of blood glucose
Multiple daily injections
ISSN:1558-4410, 1558-4410
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive automated insulin delivery enables the highest targets for time in range, lowest rate and duration of hypoglycemia, and favorable quality of life. Clear targets for time in ranges and a standard visualization of the data will help the diabetes technology to be used more efficiently. Decision support systems within and integrated cloud environment will further simplify, unify, and improve modern routine diabetes care.
AbstractList Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive automated insulin delivery enables the highest targets for time in range, lowest rate and duration of hypoglycemia, and favorable quality of life. Clear targets for time in ranges and a standard visualization of the data will help the diabetes technology to be used more efficiently. Decision support systems within and integrated cloud environment will further simplify, unify, and improve modern routine diabetes care.
Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive automated insulin delivery enables the highest targets for time in range, lowest rate and duration of hypoglycemia, and favorable quality of life. Clear targets for time in ranges and a standard visualization of the data will help the diabetes technology to be used more efficiently. Decision support systems within and integrated cloud environment will further simplify, unify, and improve modern routine diabetes care.Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive automated insulin delivery enables the highest targets for time in range, lowest rate and duration of hypoglycemia, and favorable quality of life. Clear targets for time in ranges and a standard visualization of the data will help the diabetes technology to be used more efficiently. Decision support systems within and integrated cloud environment will further simplify, unify, and improve modern routine diabetes care.
Author Dovc, Klemen
Battelino, Tadej
Author_xml – sequence: 1
  givenname: Klemen
  surname: Dovc
  fullname: Dovc, Klemen
  organization: Department of Paediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children's Hospital, University Medical Centre Ljubljana, Bohoriceva 20, Ljubljana SI-1000, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
– sequence: 2
  givenname: Tadej
  surname: Battelino
  fullname: Battelino, Tadej
  email: tadej.battelino@mf.uni-lj.si
  organization: Department of Paediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children's Hospital, University Medical Centre Ljubljana, Bohoriceva 20, Ljubljana SI-1000, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Electronic address: tadej.battelino@mf.uni-lj.si
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31980111$$D View this record in MEDLINE/PubMed
BookMark eNpNT8lOwzAUtFARXeADuKAcuSS85ziLj6iURarEpZwj23mGVE5c4gSpf08QReI0i0ajmSWbdb4jxq4REgTM7_YJGZdwQDnpBECesQVmWRkLgTD7x-dsGcIeADMo-QWbpyhLQMQFizZf3o1D47vI2-ihUZoGCtGOzEfnnX8_XrJzq1ygqxOu2NvjZrd-jrevTy_r-21sMsAh1mRsURQg6jrNDda5sEoJYTNlS2tNnfNCyR9fauBSSUta6FrYgueFJtR8xW5_ew-9_xwpDFXbBEPOqY78GCqeimxaL4Scojen6KhbqqtD37SqP1Z_r_g3RHdQqA
CitedBy_id crossref_primary_10_1007_s12020_023_03355_1
crossref_primary_10_1016_j_cmpb_2023_107700
crossref_primary_10_1172_JCI142242
crossref_primary_10_3390_s22228682
crossref_primary_10_1007_s11892_022_01468_x
crossref_primary_10_1186_s13098_022_00877_y
crossref_primary_10_1111_dme_14907
crossref_primary_10_1111_dom_15766
crossref_primary_10_1007_s00592_023_02189_7
crossref_primary_10_1007_s41745_023_00389_2
crossref_primary_10_1056_NEJMcp2112175
crossref_primary_10_1001_jamanetworkopen_2023_0077
crossref_primary_10_1089_dia_2021_2502
crossref_primary_10_1089_dia_2021_2505
crossref_primary_10_3748_wjg_v31_i23_104932
crossref_primary_10_1016_j_jddst_2024_106229
crossref_primary_10_1111_pedi_13428
crossref_primary_10_3390_math11030730
crossref_primary_10_3390_nu16020199
crossref_primary_10_1080_17434440_2022_2150546
crossref_primary_10_1111_dom_14418
crossref_primary_10_1016_j_diabres_2025_112228
crossref_primary_10_1055_a_2625_6437
crossref_primary_10_1111_dme_15339
crossref_primary_10_1111_dme_14403
crossref_primary_10_3390_asi3030031
crossref_primary_10_1016_j_diabres_2025_112154
crossref_primary_10_2337_dci20_0032
crossref_primary_10_54097_34e2tk57
crossref_primary_10_1089_dia_2022_0042
crossref_primary_10_1080_17434440_2022_2142556
crossref_primary_10_1136_bmjdrc_2025_005248
crossref_primary_10_3390_diagnostics15030258
crossref_primary_10_3390_s21051647
crossref_primary_10_1155_2023_2851620
crossref_primary_10_1371_journal_pdig_0000918
crossref_primary_10_3389_fendo_2022_967725
crossref_primary_10_1016_j_jmbbm_2023_106352
crossref_primary_10_1111_dme_14755
crossref_primary_10_1159_000524866
crossref_primary_10_1177_26350106221120889
crossref_primary_10_1016_j_diabres_2025_112286
crossref_primary_10_1007_s40265_022_01766_4
crossref_primary_10_3390_endocrines4030042
crossref_primary_10_2337_dc22_1915
crossref_primary_10_1186_s12902_025_01905_4
crossref_primary_10_1080_17434440_2020_1784724
crossref_primary_10_1159_000527653
crossref_primary_10_1210_endrev_bnaa015
crossref_primary_10_1016_j_jddst_2020_101952
ContentType Journal Article
Copyright Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
DBID NPM
7X8
DOI 10.1016/j.ecl.2019.10.009
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1558-4410
ExternalDocumentID 31980111
Genre Journal Article
Review
GroupedDBID ---
.1-
.FO
.GJ
0R~
1CY
1P~
34G
39C
4.4
457
53G
5GY
5RE
6PF
AAEDT
AAEDW
AALRI
AAQQT
AAQXK
AAWTL
AAXUO
ABFRF
ABMAC
ABOCM
ABQZK
ABWVN
ACGFO
ACRPL
ADBBV
ADMUD
ADNMO
AEFWE
AENEX
AEVXI
AFFNX
AFRHN
AFTJW
AI.
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AXIYT
AZFZN
B08
COIAO
CS3
DAHGL
DU5
EBS
EJD
EX3
F5P
FDB
FEDTE
FGOYB
HVGLF
HZ~
J5H
L7B
N4W
NPM
O9-
OB0
ON-
P2P
R2-
SEL
SES
UNMZH
VH1
WH7
WOW
Z5R
ZGI
ZXP
7X8
APXCP
ID FETCH-LOGICAL-c501t-becf77704dd36c1d64faa44f5af8ffcd627a9c1d69b029a9feb4bd4f7267be1b2
IEDL.DBID 7X8
ISICitedReferencesCount 59
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000518078700003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1558-4410
IngestDate Fri Jul 11 13:12:58 EDT 2025
Thu Jan 02 22:59:33 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Artificial pancreas
Continuous glucose monitoring
Closed loop
Insulin pump
Technology
Type 1 diabetes
Self-monitoring of blood glucose
Multiple daily injections
Language English
License Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c501t-becf77704dd36c1d64faa44f5af8ffcd627a9c1d69b029a9feb4bd4f7267be1b2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S088985291930091X?via%3Dihub
PMID 31980111
PQID 2345508449
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2345508449
pubmed_primary_31980111
PublicationCentury 2000
PublicationDate 2020-03-01
PublicationDateYYYYMMDD 2020-03-01
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Endocrinology and metabolism clinics of North America
PublicationTitleAlternate Endocrinol Metab Clin North Am
PublicationYear 2020
SSID ssj0015082
Score 2.4982328
SecondaryResourceType review_article
Snippet Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1
Title Evolution of Diabetes Technology
URI https://www.ncbi.nlm.nih.gov/pubmed/31980111
https://www.proquest.com/docview/2345508449
Volume 49
WOSCitedRecordID wos000518078700003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAIsSFfSmbgsTV0Dhe4hNCqBUHWvUAqLfIq8QlKaT0-xm7Lr0hJC45RI7kZTzzMu_Zg9CNAUgNuN1hwb3GEI8J1ia3WHPoNlGEFfGy6rdnMRqVk4kcp4Rbm2SVS58YHbVtTMiR35EinL8tKZX30w8cqkYFdjWV0FhHnQKgTLBqMVmxCNA-sp2MlRjC_g-rGfVdzgTmIZe3Udz1C8KMkWaw-98-7qGdhDGzh4VR7KM1Vx-grWFi0Q9R1p8ng8sanyVNTJutsuxH6HXQf3l8wqlSAjasl88wLIQXQvSotQWHqebUK0WpZ8qX3hvLiVAyvJe6R6SS3mmqLfWCcKFdrskx2qib2p2izJW25OD0qOIQ-RngR-mhvbG5ZlQx1kXXy7FXYImBXlC1a77aajX6LjpZTGA1XVyZUcFGL0NV-7M_fH2Otkn4qY1CrwvU8bAP3SXaNPPZe_t5FZcYnqPx8BsVorAP
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evolution+of+Diabetes+Technology&rft.jtitle=Endocrinology+and+metabolism+clinics+of+North+America&rft.au=Dovc%2C+Klemen&rft.au=Battelino%2C+Tadej&rft.date=2020-03-01&rft.eissn=1558-4410&rft.volume=49&rft.issue=1&rft.spage=1&rft_id=info:doi/10.1016%2Fj.ecl.2019.10.009&rft_id=info%3Apmid%2F31980111&rft_id=info%3Apmid%2F31980111&rft.externalDocID=31980111
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-4410&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-4410&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-4410&client=summon